1. Home
  2. ADAG vs HQI Comparison

ADAG vs HQI Comparison

Compare ADAG & HQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adagene Inc.

ADAG

Adagene Inc.

N/A

Current Price

$2.80

Market Cap

222.2M

Sector

Health Care

ML Signal

N/A

Logo HireQuest Inc. (DE)

HQI

HireQuest Inc. (DE)

N/A

Current Price

$19.07

Market Cap

232.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
ADAG
HQI
Founded
2011
2002
Country
China
United States
Employees
N/A
75000
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
222.2M
232.1M
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
ADAG
HQI
Price
$2.80
$19.07
Analyst Decision
Strong Buy
Buy
Analyst Count
6
2
Target Price
$9.91
★ $19.00
AVG Volume (30 Days)
★ 277.3K
22.1K
Earning Date
08-12-2026
11-05-2026
Dividend Yield
N/A
★ 1.28%
EPS Growth
N/A
★ 73.08
EPS
N/A
★ 0.31
Revenue
N/A
★ $30,640,000.00
Revenue This Year
N/A
$0.54
Revenue Next Year
$129.59
$5.47
P/E Ratio
★ N/A
$63.19
Revenue Growth
★ N/A
N/A
52 Week Low
$1.44
$7.38
52 Week High
$4.85
$20.84

Technical Indicators

Market Signals
Indicator
ADAG
HQI
Relative Strength Index (RSI) 34.86 59.96
Support Level $2.80 $10.22
Resistance Level $3.19 $19.01
Average True Range (ATR) 0.29 1.02
MACD -0.01 0.11
Stochastic Oscillator 16.77 57.97

Price Performance

Historical Comparison
ADAG
HQI

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

About HQI HireQuest Inc. (DE)

HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.

Share on Social Networks: